Diagnostic Laboratory Biomarker Analysis

ARID1A and/or KDM6A Mutation and CXCL13 Expression

GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery

Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

DNA Sequencing in Clinical Practice, Mayo Clinic Health Tapestry Study

Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma

Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors

Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

SARS-CoV-2 Donor-Recipient Immunity Transfer

Study of Blood Samples From Newborns With Down Syndrome

Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia

Bicalutamide in Treating Patients With Metastatic Breast Cancer

Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery

Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia

Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma

DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia

Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection